| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/09553009514551101 |
| P8608 | Fatcat ID | release_j6dppgjobfbzncwp3vo66r6vl4 |
| P698 | PubMed publication ID | 7658145 |
| P50 | author | Catharine M. West | Q41672038 |
| Richard A. Cowan | Q53407541 | ||
| P2093 | author name string | D Scott | |
| P Berry | |||
| S A Elyan | |||
| P2860 | cites work | Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity | Q41089746 |
| Cytogenetic characterization of ataxia telangiectasia (AT) heterozygotes using lymphoblastoid cell lines and chronic gamma-irradiation | Q41735015 | ||
| Evidence for a Positive Correlation between in Vitro Radiosensitivity of Normal Human Skin Fibroblasts and the Occurrence of Subcutaneous Fibrosis after Radiotherapy | Q57618644 | ||
| The Association for Radiation Research First Workshop: Report | Q59139057 | ||
| Use of an Internal Standard in Comparative Measurements of the Intrinsic Radiosensitivities of Human T-lymphocytes | Q59139064 | ||
| Use of Low-dose Rate Irradiation to Measure the Intrinsic Radiosensitivity of Human T-lymphocytes | Q59139067 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 197-203 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | International Journal of Radiation Biology | Q2093427 |
| P1476 | title | A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes | |
| P478 | volume | 68 |
| Q34983335 | ATM gene mutations in sporadic breast cancer patients from Brazil |
| Q36621015 | ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes |
| Q34145071 | ATM-heterozygous germline mutations contribute to breast cancer-susceptibility |
| Q40625318 | Analysis of secondary V(D)J rearrangements in mature, peripheral T cells of ataxia-telangiectasia heterozygotes. |
| Q36667200 | Assessment of Radiation Induced Therapeutic Effect and Cytotoxicity in Cancer Patients Based on Transcriptomic Profiling. |
| Q36696654 | Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriers |
| Q33735445 | Cellular responses to radiation and risk of breast cancer |
| Q24806302 | Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study |
| Q36291685 | Comparison between radiation-induced cell cycle delay in lymphocytes and radiotherapy response in head and neck cancer |
| Q55273319 | Exploration of genetic basis underlying individual differences in radiosensitivity within human populations using genome editing technology. |
| Q40564238 | Functional consequences of ATM sequence variants for chromosomal radiosensitivity |
| Q37202992 | Gene expression phenotype in heterozygous carriers of ataxia telangiectasia |
| Q37234933 | Gene expression signatures but not cell cycle checkpoint functions distinguish AT carriers from normal individuals |
| Q37718298 | Gene-environment interaction for polymorphisms in ataxia telangiectasia-mutated gene and radiation exposure in carcinogenesis: results from two literature-based meta-analyses of 27120 participants |
| Q36115517 | Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients |
| Q38348222 | Heterozygous ATM mutations do not contribute to early onset of breast cancer |
| Q40827862 | High levels of delayed radiation-induced apoptosis observed in lymphoblastoid cell lines from ataxia-telangiectasia patients |
| Q40708303 | In vivo mutagenic effect of very low dose radiation. |
| Q62583345 | Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations |
| Q53542781 | Low dose X-radiation adaptive response in spleen and prostate of Atm knockout heterozygous mice. |
| Q34036288 | Low levels of ATM in breast cancer patients with clinical radiosensitivity |
| Q47701251 | Lymphocyte radiosensitivity correlated with pelvic radiotherapy morbidity |
| Q59139018 | Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix |
| Q49099528 | Micronucleus induction by 60Co gamma-rays and fast neutrons in ataxia telangiectasia lymphocytes |
| Q74699973 | No predictive value of the micronucleus assay for patients with severe acute reaction of normal tissue after radiotherapy |
| Q28210364 | Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients |
| Q79329677 | Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy |
| Q41506937 | Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. |
| Q38081954 | Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes. |
| Q48016520 | Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy |
| Q34433978 | Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management |
| Q38665620 | Radiogenomics and radiotherapy response modeling. |
| Q38761174 | Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? |
| Q61895327 | Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer |
| Q40804276 | Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects |
| Q31926025 | Sources of variation in patient response to radiation treatment |
| Q34783514 | Studies on radiosensitivity from an epidemiological point of view - overview of methods and results |
| Q39034471 | T lymphocytes to predict radiation-induced late effects in normal tissues. |
| Q33892835 | The ATM gene and breast cancer: is it really a risk factor? |
| Q33696238 | Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage |
| Q43596090 | Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives |
Search more.